Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pediatrix Medical Group (DE:PDC)
FRANKFURT:PDC
RESEARCH TOOLSreports
Holding DE:PDC?
Track your performance easily
PDC Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€6.10 - €12.00
Previous Close€10.8
Volume0.00
Average Volume (3M)105.00
Market Cap
€949.73M
Enterprise Value€1.47B
Total Cash (Recent Filing)$133.20M
Total Debt (Recent Filing)$698.31M
Price to Earnings (P/E)―
Beta0.08
Next Earnings
Oct 31, 2024EPS Estimate
€0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding85,865,841
10 Day Avg. Volume0
30 Day Avg. Volume105
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.31
Price to Sales (P/S)0.52
Price to Cash Flow (P/CF)2.40
P/FCF Ratio2.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit3.48
Enterprise Value/Ebitda4.42
Forecast
1Y Price Target
€10.32Price Target Upside-4.44% Downside
Rating ConsensusHold
Number of Analyst Covering6
Pediatrix Medical Group News
PremiumCompany Announcements
Pediatrix Announces Executive Shakeup and New CFO Appointment
Bulls Say, Bears Say
Bulls Say
Financial PerformanceA clean balance sheet and depressed valuation could see free cash flow put toward share repurchase and accelerate earnings per share growth.
Portfolio RestructuringThe company provided more clarity on its portfolio restructuring plan, quantifying the expected impact, which removes a key overhang for the stock.
Revenue ManagementThe Revenue Cycle Management solution transition is on track to finish as planned, potentially implying significant EBITDA upside.
Bears Say
Financial GuidanceMD chose to reiterate rather than raise their EBITDA guide of $200m to $220m despite the solid beat, which was also ahead of internal expectations.
Market TrendsOur July Birth Tracker suggests weak trends with births declining nearly 1% y/y.
Revenue StabilitySince there was lots of uncertainty in quarter-to-quarter payor mix fluctuations, the elevated commercial mix tailwind observed in 2Q may not carry through into the back half of the year.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.47% Insiders
25.32% Mutual Funds
0.10% Other Institutional Investors
44.77% Public Companies and
Individual Investors
PDC FAQ
What was Pediatrix Medical Group’s price range in the past 12 months?
Pediatrix Medical Group lowest stock price was €6.10 and its highest was €12.00 in the past 12 months.
What is Pediatrix Medical Group’s market cap?
Currently, no data Available
When is Pediatrix Medical Group’s upcoming earnings report date?
Pediatrix Medical Group’s upcoming earnings report date is Oct 31, 2024 which is in 12 days.
How were Pediatrix Medical Group’s earnings last quarter?
Pediatrix Medical Group released its earnings results on Aug 06, 2024. The company reported €0.311 earnings per share for the quarter, beating the consensus estimate of €0.286 by €0.025.
Is Pediatrix Medical Group overvalued?
According to Wall Street analysts Pediatrix Medical Group’s price is currently Overvalued.
Does Pediatrix Medical Group pay dividends?
Pediatrix Medical Group does not currently pay dividends.
What is Pediatrix Medical Group’s EPS estimate?
Pediatrix Medical Group’s EPS estimate is €0.34.
How many shares outstanding does Pediatrix Medical Group have?
Pediatrix Medical Group has 85,865,845 shares outstanding.
What happened to Pediatrix Medical Group’s price movement after its last earnings report?
Pediatrix Medical Group reported an EPS of €0.311 in its last earnings report, beating expectations of €0.286. Following the earnings report the stock price went down -4.895%.
Which hedge fund is a major shareholder of Pediatrix Medical Group?
Among the largest hedge funds holding Pediatrix Medical Group’s share is Brandes Investment Partners LP. It holds Pediatrix Medical Group’s shares valued at 6M.
---
Pediatrix Medical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€10.32 (-4.44% Downside)
€10.32 (-4.44% Downside)
Insider Transactions
Sold Shares
Worth $701.9K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-2.96%
12-Months-Change
Fundamentals
Return on Equity
-30.55%
Trailing 12-Months
Asset Growth
-13.45%
Trailing 12-Months
Company Description
Pediatrix Medical Group
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company's solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting. MEDNAX was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.
---
PDC Earnings Call
Q2 2024
0:00 / 0:00
---
PDC Stock 12 Month Forecast
Average Price Target
€10.32
▼(-4.44% Downside)
Technical Analysis
Best Analysts Covering PDC
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+8.93%
reiterated a sell rating 6 months ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +8.93% per trade.
---